Up-front risk stratification for additional cardiovascular testing may help mitigate cardiovascular toxicities in breast cancer treatment.
Joseph S. Wallins, MD, MPH
Advertisement
Articles by Joseph S. Wallins, MD, MPH
Survivors of breast cancer face increased cardiovascular risks due to treatment-related cardiotoxicity, and understanding these risks is crucial for effective management and prevention.
Advertisement
Latest Updated Articles
Cardio-Oncology Considerations for Breast Cancer: Risk Stratification, Monitoring, and TreatmentPublished: June 26th 2025 | Updated:
Cardiovascular Considerations in Breast Cancer Treatment and SurvivorshipPublished: September 8th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
Tarlatamab May Offer New SOC for Relapsed ES-SCLC With Brain Metastases
3
Which Therapy Has the Best Efficacy in Transplant-Ineligible NDMM?
4
Companion Diagnostic Earns FDA Approval for Imlunestrant in Breast Cancer
5
